REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inova Pharmaceuticals (Singapore) Pte. Limited (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Inova Pharmaceuticals (Singapore) Pte. Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western) (sales and marketing services of medicinal and pharmaceutical product (western))

Headquarters
1 Temasek Avenue, #04-01 Millenia Tower, Singapore
Singapore; Singapore; Postal Code: 039192

Contact Details: Purchase the Inova Pharmaceuticals (Singapore) Pte. Limited report to view the information.

Basic Information
Total Employees:
Purchase the Inova Pharmaceuticals (Singapore) Pte. Limited report to view the information.
Outstanding Shares:
Purchase the Inova Pharmaceuticals (Singapore) Pte. Limited report to view the information.
Incorporation Date:
November 23, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Inova Pharmaceuticals (Singapore) Pte. Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
39.48%▲
Total operating revenue
39.48%▲
Net Profit (Loss) for the Period
3335.35%▲
Total assets
-2.73%▼
Total equity
12.28%▲
Net Profit Margin
1.94%▲
Return on Equity (ROE)
2.79%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo